VAN ECK ASSOCIATES CORP - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 287 filers reported holding GW PHARMACEUTICALS PLC in Q1 2020. The put-call ratio across all filers is 1.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
VAN ECK ASSOCIATES CORP ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$3,914,000
+60.5%
18,047
-14.6%
0.01%
+57.1%
Q4 2020$2,439,000
-47.8%
21,133
-55.9%
0.01%0.0%
Q3 2020$4,668,000
-40.8%
47,948
-25.4%
0.01%
-50.0%
Q2 2020$7,884,000
+208.1%
64,240
+119.8%
0.01%
+7.7%
Q1 2020$2,559,000
+10.7%
29,220
+32.2%
0.01%
+44.4%
Q4 2019$2,311,000
+11.4%
22,103
+22.5%
0.01%
-10.0%
Q3 2019$2,075,000
-61.8%
18,038
-42.8%
0.01%
-61.5%
Q2 2019$5,439,000
+7.7%
31,550
+5.3%
0.03%
+4.0%
Q1 2019$5,048,000
+9.4%
29,948
-36.8%
0.02%
+8.7%
Q4 2018$4,616,000
-31.2%
47,395
+22.1%
0.02%
-30.3%
Q3 2018$6,707,000
+1.9%
38,827
-17.6%
0.03%
+6.5%
Q2 2018$6,579,000
+38.9%
47,146
+12.1%
0.03%
+29.2%
Q1 2018$4,738,000
-3.2%
42,052
+13.4%
0.02%0.0%
Q4 2017$4,895,000
+29.2%
37,083
-0.7%
0.02%
+26.3%
Q3 2017$3,790,000
+77.2%
37,343
+75.0%
0.02%
+58.3%
Q2 2017$2,139,000
-40.2%
21,340
-27.8%
0.01%
-25.0%
Q1 2017$3,575,000
+180.8%
29,557
+159.5%
0.02%
+166.7%
Q4 2016$1,273,000
-60.5%
11,388
-53.1%
0.01%
-60.0%
Q3 2016$3,220,00024,2620.02%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders